What is Gem?
Gem operates at the intersection of consumer health and life sciences, focusing on the development of advanced nutritional solutions that address both human wellness and planetary sustainability. By pioneering novel applications in the nutrition space, the company distinguishes itself from traditional supplement providers through a science-first approach. Its market position is bolstered by a commitment to transparency and innovation, allowing it to capture interest from investors who prioritize long-term health outcomes and environmental impact. As a key player in the Los Angeles startup ecosystem, Gem continues to refine its business model to meet the increasing consumer demand for personalized, sustainable, and scientifically-backed nutritional products.
How much funding has Gem raised?
Gem has raised a total of $11.7M across 3 funding rounds:
Angel/Seed
$3.3M
Other Financing Round
$1.3M
Series A
$7.1M
Angel/Seed (2015): $3.3M with participation from Baseline Ventures, Tekton Ventures, QED Associates, KEC Ventures, Baroda Ventures, Birchmere Labs, Bitcoin Shop, Inc., Wavemaker Labs, RRE Ventures, and Amplify.La Capital II
Other Financing Round (2015): $1.3M led by Baseline Ventures, KEC Ventures, and RRE Ventures
Series A (2016): $7.1M, investors not publicly disclosed
Key Investors in Gem
Baseline Ventures
Baseline Ventures is a venture capital firm that invests in innovative startups across various sectors, focusing on supporting entrepreneurs to achieve significant market results and successful exits.
KEC Ventures
KEC Holdings engages in a broad range of investment activities, providing capital to everything from early-stage technology-enabled startups to late-stage private equity transactions.
RRE Ventures
RRE Ventures is a venture capital firm dedicated to supporting founders at critical stages of their business journey, focusing on long-term partnerships to foster growth and innovation.
What's next for Gem?
Looking ahead, Gem is positioned to leverage its recent capital influx to accelerate product development and market penetration. The strategic focus will likely shift toward scaling operations and enhancing its supply chain to support broader distribution. Given the current enterprise-level funding context, the company is expected to prioritize operational efficiency and the expansion of its research and development capabilities. By maintaining strong relationships with its core investor base, Gem is well-equipped to navigate the complexities of the life science market, potentially exploring new partnerships or product lines that align with its mission of planetary and human health optimization. The firm's ability to sustain growth will depend on its continued execution of its core nutritional strategy while adapting to evolving consumer preferences in the health-tech sector.
See full Gem company page
